NYSE:ABEV - AMBEV S A/S Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$4.85 -0.13 (-2.61 %)
(As of 06/18/2018 11:38 AM ET)
Previous Close$4.83
Today's Range$4.83 - $4.89
52-Week Range$4.80 - $7.43
Volume293,204 shs
Average Volume29.54 million shs
Market Capitalization$78.19 billion
P/E Ratio21.07
Dividend Yield3.02%
Beta0.57

About AMBEV S A/S (NYSE:ABEV)

AMBEV S A/S logoAmbev S.A., through its subsidiaries, produces, distributes, and sells beer, draft beer, carbonated soft drinks (CSD), other non-alcoholic beverages, malt, and food in the Americas. It operates through Latin America North, Latin America South, and Canada segments. The company offers beer primarily under the Skol, Brahma, Antarctic, Brahva, Brahva Gold, Extra, Budweiser, Bud Light, Stella Artois, Corona, Modelo Especial, Beck, Leffe, Hoegaarden, Presidente, Brahma Light, President Light, Bohemia, The One, Quilmes Clásica, Paceña, Taquiña, Huari, Becker, Báltica, Ouro Fino, Pilsen, Patricia, Labatt Blue, Alexander Keith's, Kokanee, Banks, and Deputy brands. It also provides CSD, bottled water, isotonic beverages, energy drinks, coconut water, powdered and natural juices, and ready-to-drink teas under the Guaraná Antarctica, Gatorade, H2OH!, Lipton Iced Tea, Fusion, Do Bem, Pepsi, Canada Dry, Squirt, Red Rock, Pepsi-Cola, Seven Up, and Frutee brands, as well as cereal bars. Ambev S.A. offers its products through a network of third-party distributors and a direct distribution system. The company was founded in 1885 and is headquartered in São Paulo, Brazil. Ambev S.A. is a subsidiary of Interbrew International B.V.

Receive ABEV News and Ratings via Email

Sign-up to receive the latest news and ratings for ABEV and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Beverages
Sub-IndustryN/A
SectorConsumer Staples
SymbolNYSE:ABEV
CUSIPN/A
Phone55-11-2122-1200

Debt

Debt-to-Equity Ratio0.07
Current Ratio0.94
Quick Ratio0.74

Price-To-Earnings

Trailing P/E Ratio21.07
Forward P/E Ratio19.40
P/E Growth0.91

Sales & Book Value

Annual Sales$15.01 billion
Price / Sales5.07
Cash Flow$0.3074 per share
Price / Cash15.78
Book Value$0.96 per share
Price / Book5.05

Profitability

EPS (Most Recent Fiscal Year)$0.23
Net Income$2.30 billion
Net Margins16.15%
Return on Equity24.66%
Return on Assets14.40%

Miscellaneous

Employees51,432
Outstanding Shares15,701,100,000

AMBEV S A/S (NYSE:ABEV) Frequently Asked Questions

What is AMBEV S A/S's stock symbol?

AMBEV S A/S trades on the New York Stock Exchange (NYSE) under the ticker symbol "ABEV."

How often does AMBEV S A/S pay dividends? What is the dividend yield for AMBEV S A/S?

AMBEV S A/S declared a special dividend on Monday, May 28th. Shareholders of record on Tuesday, June 19th will be given a dividend of $0.0441 per share on Monday, August 6th. The ex-dividend date is Monday, June 18th. This is a boost from AMBEV S A/S's previous special dividend of $0.02. View AMBEV S A/S's Dividend History.

How were AMBEV S A/S's earnings last quarter?

AMBEV S A/S (NYSE:ABEV) announced its quarterly earnings data on Wednesday, May, 9th. The company reported $0.05 EPS for the quarter, missing the Zacks' consensus estimate of $0.07 by $0.02. The company earned $3.59 billion during the quarter, compared to analyst estimates of $3.65 billion. AMBEV S A/S had a net margin of 16.15% and a return on equity of 24.66%. View AMBEV S A/S's Earnings History.

When is AMBEV S A/S's next earnings date?

AMBEV S A/S is scheduled to release their next quarterly earnings announcement on Thursday, July, 26th 2018. View Earnings Estimates for AMBEV S A/S.

What price target have analysts set for ABEV?

6 brokerages have issued 12 month price targets for AMBEV S A/S's shares. Their predictions range from $6.50 to $9.00. On average, they expect AMBEV S A/S's share price to reach $7.50 in the next year. View Analyst Ratings for AMBEV S A/S.

Who are some of AMBEV S A/S's key competitors?

Who are AMBEV S A/S's key executives?

AMBEV S A/S's management team includes the folowing people:
  • Mr. Bernardo Pinto Paiva, CEO & Member of Exec. Board of Officers (Age 50)
  • Mr. Ricardo Rittes de Oliveira Silva Paiva, Chief Financial & Investor Relations Officer and Member of Exec. Board of Officers (Age 43)
  • Mr. Pedro de Abreu Mariani, Corp. Affairs Exec. Officer, Gen. Counsel, Sec. & Member of Exec. Board of Officers (Age 51)
  • Mr. Fábio Vieira Kapitanovas, People & Management Exec. Officer and Member of Exec. Board of Officers (Age 40)
  • Ms. Paula Nogueira Lindenberg, Marketing Exec. Officer & Member of Exec. Board of Officers (Age 42)

Has AMBEV S A/S been receiving favorable news coverage?

Media headlines about ABEV stock have been trending somewhat positive on Monday, according to Accern. Accern identifies negative and positive press coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. AMBEV S A/S earned a news impact score of 0.12 on Accern's scale. They also assigned news stories about the company an impact score of 46.55 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the near future.

Who are AMBEV S A/S's major shareholders?

AMBEV S A/S's stock is owned by a variety of of retail and institutional investors. Top institutional investors include JPMorgan Chase & Co. (0.57%), Massachusetts Financial Services Co. MA (0.39%), BlackRock Inc. (0.24%), Manning & Napier Group LLC (0.21%), Fisher Asset Management LLC (0.19%) and Dimensional Fund Advisors LP (0.16%). View Institutional Ownership Trends for AMBEV S A/S.

Which institutional investors are selling AMBEV S A/S stock?

ABEV stock was sold by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, Manning & Napier Group LLC, Wells Fargo & Company MN, Citadel Advisors LLC, Envestnet Asset Management Inc., Altrinsic Global Advisors LLC, State of New Jersey Common Pension Fund D and Allianz Asset Management GmbH. View Insider Buying and Selling for AMBEV S A/S.

Which institutional investors are buying AMBEV S A/S stock?

ABEV stock was purchased by a variety of institutional investors in the last quarter, including American Century Companies Inc., GQG Partners LLC, Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp, Pendal Group Ltd, FIL Ltd, Fisher Asset Management LLC, Hsbc Holdings PLC and JPMorgan Chase & Co.. View Insider Buying and Selling for AMBEV S A/S.

How do I buy shares of AMBEV S A/S?

Shares of ABEV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is AMBEV S A/S's stock price today?

One share of ABEV stock can currently be purchased for approximately $4.85.

How big of a company is AMBEV S A/S?

AMBEV S A/S has a market capitalization of $78.19 billion and generates $15.01 billion in revenue each year. The company earns $2.30 billion in net income (profit) each year or $0.23 on an earnings per share basis. AMBEV S A/S employs 51,432 workers across the globe.

How can I contact AMBEV S A/S?

AMBEV S A/S's mailing address is RUA DR. RENATO PAES DE BARROS 1017 3 ANDAR PARTE, SAO PAULO D5, 04530-001. The company can be reached via phone at 55-11-2122-1200 or via email at [email protected]


MarketBeat Community Rating for AMBEV S A/S (ABEV)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  165 (Vote Outperform)
Underperform Votes:  226 (Vote Underperform)
Total Votes:  391
MarketBeat's community ratings are surveys of what our community members think about AMBEV S A/S and other stocks. Vote "Outperform" if you believe ABEV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ABEV will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.